The global urinalysis market was valued at USD 3.4 billion in 2021 and it is anticipated to grow up to USD 6.2 billion by 2031, at a CAGR of 6.2% during the forecast period.
Urinalysis is also known as urine test that uses a urine sample to examine visual, chemical and microscopic aspects of urine to assess patient health. Urinalysis tests are commonly used by healthcare providers to check or monitor specific health disorders, damage to the kidney as well as to diagnose urinary tract infections.
Download Sample PDF Of This Report:
https://www.globalinsightservices.com/request-sample/GIS10372/
Market Trends and Drivers
The growing geriatric population in developed and developing countries is anticipated to boost the market demand. The increasing prevalence of diabetes, liver, and renal diseases with aging will significantly contribute to the demand for urine tests in diagnosis. Incidence of such chronic conditions among elderly population lead to higher frequency of prescriptions for tests like creatinine, albumin, glucose, ketones, and bilirubin among others. According to the World Health Organization, the number of people aged 60 years and over is estimated to increase from 1 billion in 2020 to 1.4 billion by 2030. With increasing base of this age group, the industry is estimated to foresee tremendous growth. Additionally, higher risk of chronic kidney conditions with structural and functional changes in organs with aging will favour the testing volume.
Request Customization:
https://www.globalinsightservices.com/request-customization/GIS10372/
Global Urinalysis Market Segmental Overview
The report analyses the Global urinalysis market based on product, application, end-use, and region.
Major Players in the Global Urinalysis Market
The key players in the market are Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health, Inc. (US), Abbott Laboratories (US), Danaher Corporation (US), Sysmex Corporation (Japan), Quidel Corporation (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US), EKF Diagnostics (UK), Thermo Fisher Scientific Inc. (US), among others.
Recent Developments
In April 2022, Thermo Fisher Scientific launched newest Raman spectroscopic analyzer such as Ramina Process Analyzer, is designed to eliminate much of the complexity inherent to Raman spectroscopy measurements to prioritize user accessibility. This analyzer offers non-destructive, continuous analysis without the need for sample preparation.
In February 2021, 77 Elektronika Kft. announced the launch of LabStrip U mALB/CREA urine test strips. The product is intended for the rapid and semi-quantitative recognition of creatinine and albumin compounds in native urine. Such developments are expected to strengthen the company’s product offerings in the emerging markets.
In January 2021, ARKRAY, Inc. (Japan) launched AutionIDaten AE-4070 compact automated urine analyzer.
In August 2020, Sysmex America, Inc. announced an exclusive agreement with Siemens Healthineers that granted North American rights to distribute and service Siemens Healthineers CLINITEK Novus Automated Urine Analyzer for hospital and reference laboratory use.
Procure Complete Report (PDF with Insights, Charts, Tables, and Figures)
https://www.globalinsightservices.com/checkout/single_user/GIS10372/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1–833–761–1700
Website: https://www.globalinsightservices.com/